DeepMed Research

University of Oxford

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Established: 1096-01-01

Employees: 10K

Market Cap: -

Website: http://www.ox.ac.uk

Clinical Trials

Safety and Immunogenicity of MVA.HIVconsv in HIV-1 Seropositive Adults on HAART

Phase 1

Terminated

Conditions: HIV-1

Interventions: Biological: MVA.HIVconsv high dose
Other: Placebo high dose
Biological: MVA.HIVconsv low dose
Other: Placebo low dose

First Posted Date: 2009-12-03

Last Posted Date: 2016-06-08

Lead Sponsor: University of Oxford

Target Recruit Count: 19

Registration Number: NCT01024842

Locations: 🇬🇧
Oxford Genitourinary Medicine, Oxford, Oxon, United Kingdom
🇬🇧
Weatherall Institute of Molecular Medicine, Oxford, Oxons, United Kingdom

A Study of the Safety and Effectiveness of Two New Malaria Vaccines

Phase 1

Completed

Conditions: Malaria

Interventions: Biological: AdCh63-MSP1 (lower dose) vaccine and MVA-MSP1 vaccine
Biological: AdCh63-MSP1 vaccine (higher dose) and MVA-MSP1 vaccine followed by challenge

First Posted Date: 2009-10-28

Last Posted Date: 2011-03-28

Lead Sponsor: University of Oxford

Target Recruit Count: 16

Registration Number: NCT01003314

Locations: 🇬🇧
Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Oxford, United Kingdom

Questscope Non-Formal Education Impact Study

Phase 2

Completed

Conditions: Education
Empowerment
Self-efficacy

Interventions: Behavioral: Questscope Non-Formal Education

First Posted Date: 2009-10-26

Last Posted Date: 2011-08-04

Lead Sponsor: University of Oxford

Target Recruit Count: 200

Registration Number: NCT01001286

Locations: 🇯🇴
Al Mutasm School, Amman, Jordan
🇯🇴
Al Zubaidieh School, Amman, Jordan
🇯🇴
Ali Reda Al Rekabi School, Amman, Jordan

and more 3 locations

A Study to Assess the Safety and Efficacy of a New Influenza Candidate Vaccine MVA-NP+M1 In Healthy Adults

Phase 2

Completed

Conditions: Influenza

Interventions: Biological: MVA-NP+M1

First Posted Date: 2009-10-09

Last Posted Date: 2011-08-11

Lead Sponsor: University of Oxford

Target Recruit Count: 27

Registration Number: NCT00993083

Locations: 🇬🇧
Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Churchill Hospital, Oxford, Oxfordshire, United Kingdom
🇬🇧
Wellcome Trust Clinical Research Facility, University of Southampton, Southampton, Hampshire, United Kingdom

A Study to Assess Safety, Immunogenicity and Parasite Growth Inhibition of an Asexual Blood Stage Vaccine for P. Falciparum Malaria

Phase 1

Completed

Conditions: Malaria

Interventions: Biological: AMA1-C1/Alhydrogel® + CPG 7909

First Posted Date: 2009-09-25

Last Posted Date: 2015-05-28

Lead Sponsor: University of Oxford

Target Recruit Count: 8

Registration Number: NCT00984763

Locations: 🇬🇧
Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Oxford, Headington, United Kingdom

Swine Flu (Novel Influenza A H1N1) Vaccine Study

Phase 2

Completed

Conditions: Influenza

Interventions: Biological: Baxter Novel Influenza A H1N1 Whole Virus Vaccine
Biological: GlaxoSmithKline Novel Influenza A H1N1 Split Virion Vaccine

First Posted Date: 2009-09-21

Last Posted Date: 2013-05-09

Lead Sponsor: University of Oxford

Target Recruit Count: 1000

Registration Number: NCT00980850

Locations: 🇬🇧
St Georges Vaccine Institute, London, United Kingdom
🇬🇧
Royal Devon and Exeter NHS Foundation Trust, Exeter, United Kingdom
🇬🇧
Bristol Children's Vaccine Centre, Bristol, United Kingdom

and more 2 locations

Long Term Influenza Prophylaxis With Inhaled Zanamivir or Oral Oseltamivir

Phase 4

Completed

Conditions: Influenza

Interventions: Drug: zanamivir for inhalation
Drug: placebo capsule
Drug: placebo for inhalation
Drug: active oseltamivir

First Posted Date: 2009-09-18

Last Posted Date: 2010-09-22

Lead Sponsor: University of Oxford

Target Recruit Count: 390

Registration Number: NCT00980109

Locations: 🇹🇭
Hospital for Tropical Diseases, Bangkok, Thailand
🇹🇭
Faculty of Medicine Siriraj Hospital, Bangkok, Bangkoknoi, Thailand

Temporal Artery Biopsy vs ULtrasound in Diagnosis of GCA (TABUL)

Completed

Conditions: Giant Cell Arteritis

Interventions: Procedure: Ultrasound of temporal and axillary arteries
Procedure: Temporal artery biopsy

First Posted Date: 2009-09-10

Last Posted Date: 2015-07-17

Lead Sponsor: University of Oxford

Target Recruit Count: 880

Registration Number: NCT00974883

Locations: 🇮🇪
St Vincent's University Hospital, Dublin, Ireland
🇵🇹
Hospital de Santa Maria, Lisbon, Portugal
🇬🇧
Musgrave Park Hospital, Belfast, United Kingdom

and more 24 locations

Alteration of Deep Brain Stimulation Parameters for Dystonia

Not Applicable

Conditions: Dystonia

Interventions: Procedure: Alteration of deep brain stimulator settings

First Posted Date: 2009-09-04

Last Posted Date: 2009-10-14

Lead Sponsor: University of Oxford

Target Recruit Count: 20

Registration Number: NCT00971854

Locations: 🇬🇧
University of Oxford, Nuffield Department of Surgery, Oxford, Oxfordshire, United Kingdom

Study of the Effects of Iron on Lung Blood Pressure at High Altitude

Phase 2

Withdrawn

Conditions: Hypertension, Pulmonary

Interventions: Drug: Iron sucrose
Drug: Normal saline

First Posted Date: 2009-08-18

Last Posted Date: 2017-05-15

Lead Sponsor: University of Oxford

Registration Number: NCT00960921

Locations: 🇰🇬
Institute of Molecular Biology and Medicine, Bishkek, Kyrgyzstan

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy